ArticleJournal of experimental & clinical cancer research : CR2023

Inhibiting NR5A2 targets stemness in pancreatic cancer by disrupting SOX2/MYC signaling and restoring chemosensitivity.

Quan Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.